OBJECTIVE: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accurate predictor of type 2 diabetes. We performed a meta-analysis to determine the optimum cutoff of 1-h PG for detection of type 2 diabetes using 2-h PG as the gold standard. RESEARCH DESIGN AND METHODS: We included 15 studies with 35,551 participants from multiple ethnic groups (53.8% Caucasian) and 2,705 newly detected cases of diabetes based on 2-h PG during OGTT. We excluded cases identified only by elevated fasting plasma glucose and/or HbA1c. We determined the optimal 1-h PG threshold and its accuracy at this cutoff for detection of diabetes (2-h PG ≥11.1 mmol/L) using a mixed linear effects regression model with different weights to sen...
OBJECTIVE- Some individuals with normal glucose tolerance (NGT) exhibit a 1-h excursion of plasma gl...
To assess the use of fasting plasma glucose (FPG) alone for the screening of diabetes as defined by ...
Background/objectives: Guidelines recommend screening all patients with cardiovascular disease by or...
OBJECTIVE: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accu...
Objective: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accu...
Abstract Objective: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) ...
UNLABELLED: One hour plasma glucose (1-hr PG) concentration during an oral glucose tolerance test (O...
OBJECTIVE — To assess the efficacy of 1-h plasma glucose concentration and the metabolic syndrome in...
AimThis systematic review aimed to ascertain the diagnostic accuracy (sensitivity and specificity) o...
Aim: To assess the performance of HbA1c and the 1-h plasma glucose (PG ≥ 155 mg/dl; 8.6 mmol/l) in i...
OBJECTIVE: To assess the effect of adding an oral glucose tolerance test (OGTT) to fasting plasma gl...
Objective To assess the effect of adding an oral glucose tolerance test (OGTT) to fasting plasma glu...
OBJECTIVE To examine whether the 1-h blood glucose measurement would be a more suitable screening to...
CONTEXT: Early prediction of dysglycemia is crucial to prevent progression to type 2 diabetes. The 1...
OBJECTIVE: To compare the 1999 World Health Organization (WHO) fasting plasma glucose (FPG) criteria...
OBJECTIVE- Some individuals with normal glucose tolerance (NGT) exhibit a 1-h excursion of plasma gl...
To assess the use of fasting plasma glucose (FPG) alone for the screening of diabetes as defined by ...
Background/objectives: Guidelines recommend screening all patients with cardiovascular disease by or...
OBJECTIVE: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accu...
Objective: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accu...
Abstract Objective: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) ...
UNLABELLED: One hour plasma glucose (1-hr PG) concentration during an oral glucose tolerance test (O...
OBJECTIVE — To assess the efficacy of 1-h plasma glucose concentration and the metabolic syndrome in...
AimThis systematic review aimed to ascertain the diagnostic accuracy (sensitivity and specificity) o...
Aim: To assess the performance of HbA1c and the 1-h plasma glucose (PG ≥ 155 mg/dl; 8.6 mmol/l) in i...
OBJECTIVE: To assess the effect of adding an oral glucose tolerance test (OGTT) to fasting plasma gl...
Objective To assess the effect of adding an oral glucose tolerance test (OGTT) to fasting plasma glu...
OBJECTIVE To examine whether the 1-h blood glucose measurement would be a more suitable screening to...
CONTEXT: Early prediction of dysglycemia is crucial to prevent progression to type 2 diabetes. The 1...
OBJECTIVE: To compare the 1999 World Health Organization (WHO) fasting plasma glucose (FPG) criteria...
OBJECTIVE- Some individuals with normal glucose tolerance (NGT) exhibit a 1-h excursion of plasma gl...
To assess the use of fasting plasma glucose (FPG) alone for the screening of diabetes as defined by ...
Background/objectives: Guidelines recommend screening all patients with cardiovascular disease by or...